학술논문
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis
Document Type
Article
Author
Efe, C.; Taşçılar, K.; Gerussi, A.; Bolis, F.; Cristoferi, L.; Invernizzi, P.; Lammert, C.; Ebik, B.; Stättermayer, A.F.; Cengiz, M.; Kayhan, M.A.; Gökçe, D.T.; Peralta, M.; Silva, M.; Mendizabal, M.; Ridruejo, E.; Massoumi, H.; Montes, P.; Cerda, E.; Rigamonti, C.; Yapalı, S.; Adali, G.; Çalışkan, A.R.; Balaban, Y.; Eren, F.; Eşkazan, T.; Barutçu, S.; Lytvyak, E.; Montano-Loza, A.J.; Zazueta, G.M.; Narro, G.C.; Heurgue-Berlot, A.; De Martin, E.; Yavuz, A.; Bıyık, M.; Duman, S.; Idilman, R.; Hernandez, N.; Gatselis, N.K.; Dalekos, G.N.; Aguirre, J.; Atay, K.; Güzelbulut, F.; Dhanasekaran, R.; Wahlin, S.
Source
In: Journal of Autoimmunity . (Journal of Autoimmunity, October 2022, 132)
Subject
Language
English
ISSN
10959157
08968411
08968411